Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19
COVID-19의 심각한 진행과 관련된 염증 및 항바이러스 면역 반응
Clinical Trial
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
applied
coronavirus
coronavirus disease
coronavirus disease-2019
COVID-19
COVID-19 severity
Disease progression
disease severity
downregulation
Ex vivo
Functional enrichment analysis
H1N1
H1N1 virus
healthy controls
hemagglutinin
host immune system
hypercytokinemia
IFNs
immune cells
immune response
immune signature
impair
impaired function
include
indicate
indicated
Infection
Inflammation
Inflammatory
Inflammatory response
Influenza
influenza A
interferons
LAG3
microarray analysis
mild COVID-19 patient
MMP9
mononuclear cell
mononuclear cells
myeloid cell
myeloid cells
Neutrophils
novel respiratory disease
overactivation
overactive
patients
patients with influenza
PBMC
PBMCs
Peripheral blood
Peripheral blood mononuclear cells
potential mechanism
potential mechanisms
progression
promote
proportion
Protein
regulate
Regulation
respiratory
Respiratory disease
respond
response
SARS-CoV-2
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
severe and mild COVID-19 patients
severe COVID-19
severe SARS
severe SARS-CoV-2
severity
Signaling
SKAP1
spike
Spike protein
Stimulation
suggested
T cell
T cells
T cells
TLR6
Transcriptome
Type I IFN
type I IFNs
type I interferon
type I interferons
unique
upregulation
whole genome transcriptome
with COVID-19
[DOI] 10.3389/fimmu.2021.631226 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.3389/fimmu.2021.631226 PMC 바로가기 [Article Type] Clinical Trial